ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

American Urological Association Releases the Surgical Management of Kidney and Ureteral Stones Guideline

BALTIMORE, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Today, the American Urological Association (AUA) released the 2025 Surgical Management of Kidney and Ureteral Stones Guideline.

This Guideline is intended to facilitate care decisions and aid clinicians in the surgical management of patients with kidney and ureteral stones. The multiple surgical treatment options are discussed and evaluated within this Guideline.

"This Guideline provides clinicians with clear, comprehensive recommendations to optimize surgical outcomes for patients with kidney and ureteral stones,” said Brian Matalaga, co-chair for the Guideline. “By evaluating multiple treatment approaches and incorporating the latest data, we’ve created a resource that empowers providers to make informed decisions tailored to each patient’s needs. Ultimately, this work underscores our commitment to delivering high-quality, patient-centered care."

This Guideline has 60 recommendations and serves as a useful reference on effective evidence-based care as it relates to surgical management of kidney and ureteral stones.

This Guideline includes information on:

  • Pre-operative evaluation and preparation in patients with kidney and/or ureteral stones
  • Treatment of patients with kidney and/or ureteral stones

“This Guideline reflects years of collaboration and rigorous analysis, ensuring that clinicians have access to the most current, evidence-based strategies for managing kidney and ureteral stones. Our aim is to provide practical recommendations that improve patient outcomes and advance surgical care across diverse clinical settings," explained Dr. Margeret Pearle, co-chair for the Guideline.

The full Guideline is now available at auanet.org/StonesSurgicalManagement

A summary of the Guideline also appears at:

Pearle MS, Matlaga BR, Antonelli JA.  Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part I: Evaluation and Treatment of Patients with Kidney and/or Ureteral Stones. J Urol. 0(0). doi:10.1097/JU.0000000000004842

https://www.auajournals.org/doi/10.1097/JU.0000000000004842

Pearle MS, Matlaga BR, Antonelli JA.  Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part II: Evaluation and Treatment of Patients with Kidney and/or Ureteral Stones. J Urol. 0(0). doi:10.1097/JU.0000000000004843

https://www.auajournals.org/doi/10.1097/JU.0000000000004843

Pearle MS, Matlaga BR, Antonelli JA.  Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part III: Evaluation and Treatment of Patients with Kidney and/or Ureteral Stones. J Urol. 0(0). doi:10.1097/JU.0000000000004844

https://www.auajournals.org/doi/10.1097/JU.0000000000004844

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 24,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.

Attachment


Corey Del Bianco
American Urological Association
443-689-4033
cdelbianco@auanet.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.